Reporting Recommendations for Tumor Marker Prognostic Studies

Journal of Clinical Oncology - United States
doi 10.1200/jco.2004.01.0454
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2012English

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration

BMC Medicine
Medicine
2012English

Recommendations for Reporting Histopathology Studies: A Proposal

Virchows Archiv
MedicineForensic MedicinePathologyCell BiologyMolecular Biology
2015English

Recommendations for Memory B Cell Reporting

Pathology
Forensic MedicinePathology
2020English

Development of EULAR Recommendations for the Reporting of Clinical Trial Extension Studies in Rheumatology

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2014English

Recommendations for Standardised Reporting of Protein Electrophoresis

Pathology
Forensic MedicinePathology
2020English

Recommendations for Standardised Reporting of Protein Electrophoresis

Pathology
Forensic MedicinePathology
2020English

L1TD1 - A Prognostic Marker for Colon Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

MT1G Hypermethylation: A Potential Prognostic Marker for Hepatoblastoma

Pediatric Research
Child HealthPediatricsPerinatology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy